Literature DB >> 10217395

Use of claims data for research on treatment and outcomes of depression care.

C A Melfi1, T W Croghan.   

Abstract

BACKGROUND: Data sources such as medical insurance claims are increasingly used in outcomes research. In this report, we present opportunities and limitations associated with the use of such data for outcomes research in the area of depression.
OBJECTIVES: The purpose of this report is to illustrate the use of administrative claims data in conducting research in the area of depression. Information in this report is intended to be helpful to both experienced health services researchers and to those who may be new to the field of either outcomes research or mental health research. FORMAT: This report covers measurement of outcomes, possible data sources, episode construction, and statistical methodologies that are appropriate when conducting depression research using claims data. Through examples and references, issues to be considered in each of these areas are examined and recommendations are made. Strengths and limitations of claims data will also be pointed out.
CONCLUSIONS: The use of claims data to conduct outcomes research in depression should be carried out responsibly. Limitations with using claims data to identify patients with depression must be acknowledged and appropriate methodologies should be used. Still, these data sources provide a rich opportunity to conduct outcomes research in depression, and much can be learned using administrative claims data.

Entities:  

Mesh:

Year:  1999        PMID: 10217395     DOI: 10.1097/00005650-199904001-00010

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  11 in total

1.  Antidepressant medication use before and after kidney transplant: implications for outcomes - a retrospective study.

Authors:  Krista L Lentine; Abhijit S Naik; Rosemary Ouseph; Zidong Zhang; David A Axelrod; Dorry L Segev; Vikas R Dharnidharka; Daniel C Brennan; Henry Randall; Raj Gadi; Ngan N Lam; Gregory P Hess; Bertram L Kasiske; Mark A Schnitzler
Journal:  Transpl Int       Date:  2017-08-03       Impact factor: 3.782

2.  An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.

Authors:  Gerald Cochran; Adam J Gordon; Wei-Hsuan Lo-Ciganic; Walid F Gellad; Winfred Frazier; Carroline Lobo; Chung-Chou H Chang; Ping Zheng; Julie M Donohue
Journal:  Med Care       Date:  2017-03       Impact factor: 2.983

3.  Medicaid prior authorization and opioid medication abuse and overdose.

Authors:  Gerald Cochran; Adam J Gordon; Walid F Gellad; Chung-Chou H Chang; Wei-Hsuan Lo-Ciganic; Carroline Lobo; Evan Cole; Winfred Frazier; Ping Zheng; David Kelley; Julie M Donohue
Journal:  Am J Manag Care       Date:  2017-05-01       Impact factor: 2.229

4.  Longterm persistence and nonrecurrence of depression treatment in Germany: a four-year retrospective follow-up using linked claims data.

Authors:  Christoph J Wagner; Charalabos Markos Dintsios; Florian G Metzger; Helmut L'Hoest; Ursula Marschall; Bjoern Stollenwerk; Stephanie Stock
Journal:  Int J Methods Psychiatr Res       Date:  2018-02-15       Impact factor: 4.035

Review 5.  The need for an iterative process for assessing economic outcomes associated with SSRIs.

Authors:  T L Skaer; D A Sclar; L M Robison; R S Galin
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

6.  Depression diagnoses after living kidney donation: linking U.S. Registry data and administrative claims.

Authors:  Krista L Lentine; Mark A Schnitzler; Huiling Xiao; David Axelrod; Connie L Davis; Melanie McCabe; Daniel C Brennan; Sheila Leander; Amit X Garg; Amy D Waterman
Journal:  Transplantation       Date:  2012-07-15       Impact factor: 4.939

7.  The medical care utilization and costs associated with migraine headache.

Authors:  Jennifer Elston Lafata; Christina Moon; Carol Leotta; Ken Kolodner; Laila Poisson; Richard B Lipton
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

8.  Optimizing the control group for evaluating ART outcomes: can outpatient claims data yield a better control group?

Authors:  Judy E Stern; Chia-Ling Liu; Xiaohui Cui; Daksha Gopal; Howard J Cabral; Charles C Coddington; Stacey A Missmer; Sunah S Hwang; Leslie V Farland; Dmitry Dukhovny; Hafsatou Diop
Journal:  J Assist Reprod Genet       Date:  2021-02-19       Impact factor: 3.412

9.  The epidemiology of antidepressant use in South Korea: Does short-term antidepressant use affect the relapse and recurrence of depressive episodes?

Authors:  Min Ji Kim; Namwoo Kim; Daun Shin; Sang Jin Rhee; C Hyung Keun Park; Hyeyoung Kim; Sung Joon Cho; Jae Won Lee; Eun Young Kim; Boram Yang; Yong Min Ahn
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

10.  Racial and Ethnic Disparities in Treatment and Treatment Type for Depression in a National Sample of Medicaid Recipients.

Authors:  Brian McGregor; Chaohua Li; Peter Baltrus; Megan Douglas; Jammie Hopkins; Glenda Wrenn; Kisha Holden; Ebony Respress; Anne Gaglioti
Journal:  Psychiatr Serv       Date:  2020-04-02       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.